Medtech Convergence Fund - aVenture Asset Manager Research
Location
Boston, MA, US
Founded
2020
Medtech Convergence Fund (MCF) is a seed and early-stage venture capital fund focused on innovative medical technology companies. The fund targets the convergence of medtech with software, telecommunications, and new service models to address significant health challenges. MCF typically invests in Series A rounds, with occasional participation in later stages.
MCF's portfolio includes companies like Alpheus Medical, CarePredict, Nanopath, and Podimetrics. The fund leverages decades of medtech investing and operating experience to support entrepreneurs, healthcare professionals, and inventors. MCF aims to transform healthcare by investing in advanced materials science, component miniaturization, sensors, software, and new delivery models.
Medtech Convergence Fund - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies4
Current Portfolio Count4
Top Investment Stages
Series A3 (75.0%)
Series C1 (25.0%)
Stage Mix
Series A 75%Series C 25%
Concentration shown as share of disclosed investments by stage.